Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Pharmacogenet Genomics. 2010 Nov;20(11):665–676. doi: 10.1097/FPC.0b013e32833f2cd0

Table 1. Demographics of UK and US JIA patient cohorts.

UK cohort US cohort
 Number of cases 197 210
JIA Subtype at time of starting MTX (in %) :
Oligoarticular Persistent 9.1 8.6
Oligoarticular Extended 26.4 20.9
Polyarticular RF- 37.6 67.6
Polyarticular RF+ 5.6 1.9
Enthesitis related arthritis 6.0 0
Psoriatic 2.5 0.95
Systemic 10.7 0
Unclassified 2.0 0
Female (%) 132 (67%) 164 (78%)
Median and range of disease duration at starting MTX (decimal years) 1.00, 11.53 1.08, 15.8
Median and range of age at starting MTX (decimal years) 7.93, 14.97 7.25, 18.91
Median and range of active joints at start of MTX 6, 34 8, 61
Median and range of restricted joints at start of MTX 4, 41 4, 44